Cannabis Strategic Ventures
Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.
Cannabis Strategic Ventures (NUGS) - Total Assets
Latest total assets as of June 2022: $10.85 Million USD
Based on the latest financial reports, Cannabis Strategic Ventures (NUGS) holds total assets worth $10.85 Million USD as of June 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cannabis Strategic Ventures - Total Assets Trend (2014–2022)
This chart illustrates how Cannabis Strategic Ventures’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cannabis Strategic Ventures - Asset Composition Analysis
Current Asset Composition (March 2022)
Cannabis Strategic Ventures's total assets of $10.85 Million consist of 17.9% current assets and 82.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.2% |
| Accounts Receivable | $291.90K | 2.6% |
| Inventory | $1.66 Million | 14.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $100.00K | 0.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2022)
This chart illustrates how Cannabis Strategic Ventures's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cannabis Strategic Ventures's current assets represent 17.9% of total assets in 2022, a decrease from 100.0% in 2014.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2022, down from 20.7% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 14.8% of total assets.
Cannabis Strategic Ventures Competitors by Total Assets
Key competitors of Cannabis Strategic Ventures based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Cannabis Strategic Ventures - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Cannabis Strategic Ventures generates 0.88x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Cannabis Strategic Ventures is currently not profitable relative to its asset base.
Cannabis Strategic Ventures - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.13 | 0.18 | 10.30 |
| Quick Ratio | 0.00 | 0.05 | 10.30 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-15.39 Million | $ -14.95 Million | $ 608.26K |
Cannabis Strategic Ventures - Advanced Valuation Insights
This section examines the relationship between Cannabis Strategic Ventures's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 113.91 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -30.2% |
| Total Assets | $11.17 Million |
| Market Capitalization | $0.95 USD |
Valuation Analysis
Below Book Valuation: The market values Cannabis Strategic Ventures's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Cannabis Strategic Ventures's assets decreased by 30.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cannabis Strategic Ventures (2014–2022)
The table below shows the annual total assets of Cannabis Strategic Ventures from 2014 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-03-31 | $11.17 Million | -30.22% |
| 2021-03-31 | $16.01 Million | -9.75% |
| 2020-03-31 | $17.74 Million | +525.37% |
| 2019-03-31 | $2.84 Million | -77.19% |
| 2018-03-31 | $12.44 Million | +18561188.06% |
| 2017-03-31 | $67.00 | 0.00% |
| 2016-03-31 | $67.00 | -97.63% |
| 2015-03-31 | $2.82K | -86.56% |
| 2014-03-31 | $21.00K | -- |